Screening method for detecting staphylococci with reduced susceptibility to teicoplanin. (Q64892243)

30 June 2019

title

Screening method for detecting staphylococci with reduced susceptibility to teicoplanin. (English)

1 reference

30 June 2019

author name string

Park YJ

1

1 reference

30 June 2019

Kim M

2

1 reference

30 June 2019

Oh EJ

3

1 reference

30 June 2019

Lee SO

4

1 reference

30 June 2019

Kim BK

5

1 reference

30 June 2019

Kim SM

6

1 reference

30 June 2019

publication date

1 April 2000

1 reference

30 June 2019

Journal of Microbiological Methods

published in

1 reference

30 June 2019

volume

40

1 reference

30 June 2019

issue

2

1 reference

30 June 2019

page(s)

193-198

1 reference

30 June 2019

Gram-positive resistance: challenge for the development of new antibiotics

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Quality assessment of glycopeptide susceptibility tests: a European collaborative study. European Glycopeptide Resistance Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Emergence of teicoplanin-resistant coagulase-negative staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Evaluation of the Epsilometer test (E test) for testing the susceptibility of coagulase-negative staphylococci to teicoplanin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7012%2800%2900124-X

7 January 2021

10.1016/S0167-7012(00)00124-X

Identifiers

DOI

1 reference

30 June 2019

1 reference

30 June 2019